Crinetics Pharmaceuticals, Inc. (CRNX)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Product Net Revenue	5.42M	-
Collaboration and License Revenue	2.28M	1.04M
Collaboration and License Revenue Growth	119.06%	-74.11%
Revenue (Total)	7.70M	1.04M
Revenue (Total) Growth	640.71%	-74.11%

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error